Efficacy and safety of combining pentoxifylline with angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in diabetic nephropathy: a meta-analysis

被引：0
|
作者：
Mao-Lu Tian
Yan Shen
Zhao-Lin Sun
Yan Zha
机构：
[1] Guizhou Provincial People’s Hospital,Institute of Nephritic and Urinary Disease, Department of Nephrology
[2] Guizhou Provincial People’s Hospital,Institute of Nephritic and Urinary Disease, Department of Urology
来源：
International Urology and Nephrology | 2015年 / 47卷
关键词：
Diabetic nephropathy; Pentoxifylline; Angiotensin-converting enzyme inhibitors; Angiotensin receptor blockers; Randomized controlled trails;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：815 / 822
页数：7
相关论文
共 50 条
  • [11] Safety and tolerability of angiotensin-converting enzyme inhibitor versus the combination of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker in patients with left ventricular dysfunction: A systematic review and meta-analysis of Randomized controlled trials
    Lakhdar, Rachid
    Al-Mallah, Mouaz H.
    Lanfear, David E.
    JOURNAL OF CARDIAC FAILURE, 2008, 14 (03) : 181 - 188
  • [12] Urinary angiotensin-converting enzyme 2 increases in diabetic nephropathy by angiotensin II type 1 receptor blocker olmesartan
    Abe, Masanori
    Oikawa, Osamu
    Okada, Kazuyoshi
    Soma, Masayoshi
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2015, 16 (01) : 159 - 164
  • [13] Efficacy and Safety of Angiotensin-Converting Enzyme Inhibitor in Combination with Angiotensin-Receptor Blocker in Chronic Kidney Disease Based on Dose: A Systematic Review and Meta-Analysis
    Zhao, Mingming
    Wang, Rumeng
    Yu, Yi
    Chang, Meiying
    Ma, Sijia
    Zhang, Hanwen
    Qu, Hua
    Zhang, Yu
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [14] ALDOSTERONE BREAKTHROUGH DURING COMBINED ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND ANGIOTENSIN II RECEPTOR BLOCKER IN PATIENTS WITH IGA NEPHROPATHY
    Horita, Yoshio
    Tadokoro, Masato
    Taura, Kouichi
    Taguchi, Takashi
    Miyazaki, Masanobu
    Kohno, Shigeru
    NEPHROLOGY, 2005, 10 : A37 - A37
  • [15] Angiotensin-converting enzyme inhibitors and type 2 diabetic nephropathy: A meta-analysis
    Hamilton, RA
    Kane, MP
    Demers, J
    PHARMACOTHERAPY, 2003, 23 (07): : 909 - 915
  • [16] Design of Combination Angiotensin Receptor Blocker and Angiotensin-Converting Enzyme Inhibitor for Treatment of Diabetic Nephropathy (VA NEPHRON-D)
    Fried, Linda F.
    Duckworth, William
    Zhang, Jane Hongyuan
    O'Connor, Theresa
    Brophy, Mar
    Emanuele, Nicholas
    Huang, Grant D.
    McCullough, Peter A.
    Palevsky, Paul M.
    Seliger, Stephen
    Warren, Stuart R.
    Peduzzi, Peter
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 (02): : 361 - 368
  • [17] Design of Combination Angiotensin Receptor Blocker and Angiotensin-Converting Enzyme Inhibitor for Treatment of Diabetic Nephropathy (VA NEPHRON-D)
    Emanuele, Nicholas
    Fried, Linda F.
    Zhang, Jane Hongyuan
    O'Connor, Theresa
    Brophy, Mary
    Huang, Grant D.
    McCullough, Peter A.
    Palevsky, Paul M.
    Seliger, Stephen
    Warren, Stuart R.
    Conner, Todd
    Peduzzi, Peter
    Duckworth, William
    DIABETES, 2010, 59 : A592 - A592
  • [18] Combined therapy with an angiotensin II receptor blocker and an angiotensin-converting enzyme inhibitor in heart failure
    Struckman, DR
    Rivey, MP
    ANNALS OF PHARMACOTHERAPY, 2001, 35 (02) : 242 - 248
  • [19] Effectiveness of angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker on atrial natriuretic peptide
    Sata, N
    Tanaka, Y
    Suzuki, S
    Kamimura, R
    Mifune, H
    Nakamura, K
    Miyahara, K
    Arima, T
    CIRCULATION JOURNAL, 2003, 67 (12) : 1053 - 1058
  • [20] Onset of Hyperkalemia following the Administration of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker
    Jun, Hye-Ran
    Kim, Hyunah
    Lee, Seung-Hwan
    Cho, Jae Hyoung
    Lee, Hyunyong
    Yim, Hyeon Woo
    Yoon, Kun-Ho
    Kim, Hun-Sung
    CARDIOVASCULAR THERAPEUTICS, 2021, 2021
12345